v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Millions
Total
Class A and Class B Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021   507,170,365        
Beginning balance at Dec. 31, 2021 $ 1,091 $ 0 $ 0 $ 2,194 $ (1,102) $ (1)
Beginning balance (in shares) at Dec. 31, 2021     225,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Repurchase of common stock (in shares)   (33,475)        
Issuance of common stock upon net exercise of common stock warrants (in shares)   371,573        
Issuance of common stock upon net exercise of common stock warrants 18     18    
Issuance of common stock upon exercise of common stock options (in shares)   6,360,377        
Issuance of common stock upon exercise of common stock options 12     12    
Issuance of common stock upon vesting of restricted stock units (in shares)   3,511,292        
Stock-based compensation expense 172     172    
Vesting of restricted stock 3     3    
Issuance of common stock in connection with business combinations (in shares)   1,375,407        
Issuance of common stock in connection with business combinations 1     1    
Currency translation adjustments (1)         (1)
Unrealized gain (loss) on marketable securities (2)         (2)
Net loss (175)       (175)  
Ending balance (in shares) at Sep. 30, 2022   518,755,539        
Ending balance at Sep. 30, 2022 1,119 $ 0 $ 0 2,400 (1,277) (4)
Ending balance (in shares) at Sep. 30, 2022     225,000      
Beginning balance (in shares) at Dec. 31, 2021   507,170,365        
Beginning balance at Dec. 31, 2021 1,091 $ 0 $ 0 2,194 (1,102) (1)
Beginning balance (in shares) at Dec. 31, 2021     225,000      
Ending balance (in shares) at Dec. 31, 2022   523,027,298        
Ending balance at Dec. 31, 2022 $ 1,098 $ 0 $ 0 2,477 (1,377) (2)
Ending balance (in shares) at Dec. 31, 2022 225,000   225,000      
Beginning balance (in shares) at Jun. 30, 2022   513,406,811        
Beginning balance at Jun. 30, 2022 $ 1,150 $ 0 $ 0 2,334 (1,179) (5)
Beginning balance (in shares) at Jun. 30, 2022     225,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of common stock options (in shares)   1,950,077        
Issuance of common stock upon exercise of common stock options 5     5    
Issuance of common stock upon vesting of restricted stock units (in shares)   2,060,423        
Stock-based compensation expense 60     60    
Vesting of restricted stock 1     1    
Issuance of common stock in connection with business combinations (in shares)   1,338,228        
Currency translation adjustments 0          
Unrealized gain (loss) on marketable securities 1         1
Net loss (98)       (98)  
Ending balance (in shares) at Sep. 30, 2022   518,755,539        
Ending balance at Sep. 30, 2022 1,119 $ 0 $ 0 2,400 (1,277) (4)
Ending balance (in shares) at Sep. 30, 2022     225,000      
Beginning balance (in shares) at Dec. 31, 2022   523,027,298        
Beginning balance at Dec. 31, 2022 $ 1,098 $ 0 $ 0 2,477 (1,377) (2)
Beginning balance (in shares) at Dec. 31, 2022 225,000   225,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Repurchase of common stock (in shares)   (44,440)        
Issuance of common stock upon net exercise of common stock warrants (in shares)   19,494        
Issuance of common stock upon net exercise of common stock warrants $ 1     1    
Issuance of common stock upon exercise of common stock options (in shares) 6,479,120 6,479,120        
Issuance of common stock upon exercise of common stock options $ 20     20    
Issuance of common stock upon vesting of restricted stock units (in shares)   7,733,268        
Stock-based compensation expense 216     216    
Vesting of restricted stock 2     2    
Issuance of common stock under employee stock purchase plan (in shares)   727,849        
Issuance of common stock under employee stock purchase plan 11     11    
Issuance of common stock in connection with business combinations (in shares)   65,962        
Issuance of common stock in connection with business combinations 1     1    
Currency translation adjustments 0          
Unrealized gain (loss) on marketable securities 0          
Charitable contribution stock-based expense (in shares)   546,889        
Issuance of common stock in connection with charitable contribution 10     10    
Net loss (210)       (210)  
Ending balance (in shares) at Sep. 30, 2023   538,555,440        
Ending balance at Sep. 30, 2023 $ 1,149 $ 0 $ 0 2,738 (1,587) (2)
Ending balance (in shares) at Sep. 30, 2023 225,000   225,000      
Beginning balance (in shares) at Jun. 30, 2023   532,936,724        
Beginning balance at Jun. 30, 2023 $ 1,079 $ 0 $ 0 2,637 (1,556) (2)
Beginning balance (in shares) at Jun. 30, 2023     225,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of common stock options (in shares)   1,688,813        
Issuance of common stock upon exercise of common stock options 9     9    
Issuance of common stock upon vesting of restricted stock units (in shares)   2,942,251        
Stock-based compensation expense 75     75    
Issuance of common stock under employee stock purchase plan (in shares)   440,763        
Issuance of common stock under employee stock purchase plan 7     7    
Currency translation adjustments 0          
Unrealized gain (loss) on marketable securities 0          
Charitable contribution stock-based expense (in shares)   546,889        
Issuance of common stock in connection with charitable contribution 10     10    
Net loss (31)       (31)  
Ending balance (in shares) at Sep. 30, 2023   538,555,440        
Ending balance at Sep. 30, 2023 $ 1,149 $ 0 $ 0 $ 2,738 $ (1,587) $ (2)
Ending balance (in shares) at Sep. 30, 2023 225,000   225,000